AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

Events

AGORA PRS Seminar | March 17th

More information

Events

Ludwig Distinguished Lecture, Dr. Daniel Kirschenbaum | March 19th

More information

Events

Oncology Grand Rounds, Dr Homicsko Krisztian | March 20th

More information

Events

DOF Seminar, Prof. Ernst Lengyel | March 20th

More information

Events

AGORA Single-cell omics meetings | April 1st

More information

Highlighted publication

The evolving landscape of brain metastasis: volume II

Valiente M, Anders C, Boire A, (…), Winkler F, Zadeh G, Joyce JA

Trends in Cancer – 2026 Feb 10

Highlighted publication

CCL3 is produced by aged neutrophils across cancers and promotes tumor growth

Bolli E, Wirapati P, Hicham M, (…), Mercier F, Manguso R, Pittet MJ

Cancer Cell – 2026 Feb 5

Highlighted publication

Hallmarks of cancer—Then and now, and beyond

Hanahan D

Cell – 2026 Jan 29

Highlighted publication

Tumor-derived aminopeptidase N promotes early stages of brain metastatic colonization.

Bejarano L, Hernández-Barranco A, Roh V, (…), Hegi ME, Fournier N, Joyce JA

Cell Reports – 2026 Feb 24

Events

AGORA PRS Special Guest Seminar, Prof. Leila Akkari | March 10th

More information

Events

Oncology Grand Rounds, Prof. Bernhard Gentner | March 6th

More information

Highlighted publication

Positioning and reversible suppression of CCR7(+) dendritic cells in perivascular tumor niches shape cancer immunity.

Zitti B, Duval F, Wirapati P, (…), Böttcher JP, Weissleder R, Pittet MJ

Immunity – 2025 Dec 19

Past news

Latest publications

Is CXCR4 Theranostics in Oncologic, Cardiovascular, and Inflammatory Diseases Really Happening?

Hartrampf PE, Werner RA, Higuchi T, Schottelius M, Buck AK

Journal of nuclear medicine – 2026 Mar 12

Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma.

Roncelli F, Snider S, Boselli D, (…), Villa C, Mortini P, Gagliardi F

Journal of neuro-oncology – 2026 Mar 7

Swiss-PO 2025: Advancing Cancer Mutation and Structural Analysis for Precision Oncology With the Latest Release.

Krebs FS, Michielin O, Zoete V

JCO precision oncology – 2026 Mar 2

The value of positron emission tomography scan in predicting pathologic response of non-small cell lung cancer managed by neoadjuvant chemo-immunotherapy.

Chriqui LE, Zaher M, Abdelnour-Berchtold E, (…), Krueger T, Schaefer N, Perentes JY

Journal of thoracic disease – 2026 Feb 26

Tumor-derived aminopeptidase N promotes early stages of brain metastatic colonization.

Bejarano L, Hernández-Barranco A, Roh V, (…), Hegi ME, Fournier N, Joyce JA

Cell Reports – 2026 Feb 24